Advertisement
Advertisement

RPRX

RPRX logo

Royalty Pharma plc Class A Ordinary Shares

57.97
USD
Sponsored
+1.20
+2.11%
Aug 10, 16:00 UTC -4
Closed
exchange

After-Market

58.22

+0.25
+0.43%

Royalty Pharma plc Class A Ordinary Shares Profile

About

Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko and Trikafta, and development-stage product candidates. Royalty Pharma plc is based in NEW YORK.

Info & Links

CEO

Pablo Legorreta

Headquarters

110 East 59th Street
New York, NY 10022, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.royaltypharma.com

Auditor

Ernst & Young LLP

Share holders

7

Employees

100

Royalty Pharma plc Class A Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

25.92B

Enterprise Value

34.07B

Enterprise Value/EBITDA(ttm)

22.02

Price to Earnings Ratio(ttm)

10.81

Price to Sales(ttm)

12.89

Price to Book(mrq)

3.34

Price to Cash(ytd)

11.89

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

115.54%

Profit Margin(ttm)

32.66%

Return on Equity(ttm)

30.01%

Return on Invested Capital(ttm)

7.35%

Return on Assets(ttm)

14.91%

Income Statement

Revenue(ttm)

2.54B

Revenue Per Share(ttm)

4.41

Gross Profit(ttm)

2.54B

EBITDA(ttm)3

1.55B

Net Income Available to Common(ttm)

812.00M

Diluted EPS(ttm)

1.45

Share Statistics

Beta (5Y Monthly)

0.43

52-Week Change

54.26%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

575.00M

Dividend Yield

1.66%

Float4

467.35M

% Held by Insiders

18.84%

% Held by Institutions

54.35%

Balance Sheet

Total Cash(mrq)

836.99M

Total Cash Per Share(mrq)

1.46

Total Debt(mrq)

8.96B

Total Debt/Equity(mrq)

91.58%

Current Ratio(mrq)

2.80%

Quick Ratio(mrq)

2.80%

Book Value Per Share(mrq)

9.73

Cash Flow

Operating Cash Flow Per Share(ytd)

2.60

Free Cash Flow(ytd)

743.31M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement